Reproduction 3.0
By Leah Ramsay,
Berman Institute of Bioethics Bulletin
| 02. 26. 2015
Untitled Document
The House of Lords in the United Kingdom voted to allow fertility clinics to apply for licenses to perform “mitochondrial donation” IVF procedures on Tuesday. The UK is the first nation to explicitly allow the procedure, which it had previously banned; the resulting child would have genetic material from her parents and also from a donor of mitochondrial DNA (mtDNA), with the aim of avoiding transmission of debilitating mitochondrial disease from mother to child. The procedure has never been performed in humans.
Meanwhile, in the United States, the Food and Drug Administration (FDA) is considering clinical trials to test the procedure in humans, and is conducting inquiry into safety as well as ethical and social policy considerations.
The procedure is considered controversial because some say it would cross the “germ line,” or make a permanent, engineered change to the DNA that is passed down from mother to child. Previously this has been seen as an ethical line not to be crossed, but recently scientists and ethics scholars have come out in favor of its potential to allow...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...